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Chickenpox is a benign and self-limiting viral exanthematous infection caused by varicella-zoster virus (VZV) but sometimes may associate with complications. Mild 
thrombocytopenia associated with chickenpox is well described 
in the pediatric population, but severe thrombocytopenia with 
bleeding is rare. Various mechanisms have been implicated in 
its pathogenesis. We report a case of severe thrombocytopenia, 
possibly immune-mediated with bleeding in the form of epistaxis 
in a child recovering from chickenpox, who is successfully treated 
with steroids.
CASE REPORT
A 9-year-male child was referred to us with increasing 
thrombocytopenia and bleeding from nose for 3 days (platelet 
counts <10 × 109/L for past 3 days). The patient had a history of 
fever of 4 days followed by pleomorphic vesicular skin lesions 
of chickenpox 12 days back. There was no history of cough, 
vomiting, icterus, and bleeding from other sites. The patient was 
afebrile and was recovering from chickenpox. On examination, 
the patient was conscious and oriented, with pulse - 90/min, 
respiratory rate - 24/min, temperature 37°C by axilla, blood 
pressure 100/60 mmHg, and maintaining 99% oxygen saturation 
on room air. The patient had few dried scabbed lesions scattered 
over the body and numerous petechiae over both upper and lower 
extremities. The patient was having active bleeding in form of 
diffuse oozing from multiple sites of both nostrils,leading to 
decline in previously documented hemoglobin (Hb) of 10 g/dL 
to 8.1 g/dL at the time of admission, which failed to stop with 
the initial local treatment (compression followed by plugging the 
nostrils with gauze soaked in topical decongestant), and so nasal 
packing was done along with platelets transfusion. There was no 
hepatosplenomegaly, lymphadenopathy, ecchymosis, bruises, 
bony tenderness, and no past and family history of transfusion of 
blood components.
Laboratory investigations were as follows. Hb 8.1 g/dL, 
hematocrit 24.8%, red blood cell (RBC) count 4.28 × 106/µL, mean 
corpuscular volume - 78.3 fL, mean corpuscular Hb - 25.23 pg, 
mean corpuscular Hb concentration - 32.24 g/dL, white blood cell 
(WBC) count 12.3 × 109/L, platelet count 5 × 109/L, reticulocyte 
count 1.8%, urea 21.74 mg/dL, creatinine 0.74 mg/dL, bilirubin 
total/direct - 0.56/0.29 mg/dL, serum glutamic pyruvic 
transaminase - 22.98 U/L, serum glutamic oxaloacetic 
transaminase - 26.52 U/L, and prothrombin time/activated partial 
thrombin time/INR - 14 s/31 s/1.16, respectively. Malaria parasite 
and dengue Ns1Ag/immunoglobulin M (IgM)/IgG were negative. 
Peripheral blood smear showed microcytic hypochromic RBCs 
with anisocytosis and polychromasia. WBC count was normal 
with lymphocytosis. Platelets were markedly reduced with few 
large size platelets, no clumps seen. There was no evidence of 
hemolysis and hemoparasites. Urinalysis was normal.
Coombs test (direct antiglobulin test) was negative. 
Human immunodeficiency virus and antinuclear antibody 
titer were negative. Varicella IgM index was >2.30 (reference 
ABSTRACT
Chickenpox is a benign and self-limiting viral exanthematous infection, but sometimes it may be associated with complications. 
Mild thrombocytopenia occurs in 1-2% of children with varicella, but severe immune-mediated thrombocytopenia associated with 
bleeding is a rare complication. Various other mechanisms for thrombocytopenia have been implicated-decreased bone marrow 
production of platelets, disseminated intravascular coagulation, virally-induced platelet aggregation followed by phagocytosis 
or lysis, direct viral invasion of platelet precursors and viral-derived neuraminidase causing enzymatic desialylation of platelets 
followed by removal of abnormal platelets by reticuloendothelial system. We report a case of severe thrombocytopenia, possibly 
immune-mediated with bleeding in the form of petechiae and epistaxis in a child recovering from chickenpox, who is successfully 
treated with steroids. This may at least in part guide clinicians to recognize this rare but potentially dangerous complication of 
chickenpox.
Key words: Chickenpox, Epistaxis, Immune thrombocytopenic purpura, Petechiae
Vol 4 | Issue 4 | Oct - Dec 2017 Indian J Child Health 642
Kumar Varicella-associated immune thrombocytopenic purpura
value: ≥1 positive) and IgG index was 755.3 (reference value: 
≥150 positive). Bone marrow examination revealed adequate 
cellularity. Erythropoiesis was predominantly normoblastic 
with micronormoblasts. M: E ratio was 3:1. Myelogram showed 
blasts 3%, promyelocytes 15, myelocytes 18%, metamyelocytes 
20%, neutrophils 39%, lymphocytes 16%, monocytes 2%, and 
eosinophils 1%. Megakaryocytes were increased in number. On 
the basis of history, clinical examination and investigations, a 
diagnosis of post-varicella immune thrombocytopenic purpura 
(ITP) was made. Short course of steroid was started along with 
supportive iron and multivitamin therapy. There was a rapid rise 
in platelet counts, 154 × 109/L on the 4th day of starting steroid 
with cessation of bleeding and no new hemorrhagic lesions, and 
the patient discharged. The patient had normal hemogram on 
follow-up examination, after 1 and 3 months of hospitalization.
DISCUSSION
Mild thrombocytopenia occurs in 1-2% of children with varicella, 
but severe immune-mediated thrombocytopenia (ITP) associated 
with bleeding is rare [1]. In a retrospective study by Amir et al., 
the incidence of post-varicella ITP was 1.9% among children 
diagnosed with ITP and 1.1% among children hospitalized for 
varicella. The male-to-female ratio was 1.5:1. ITP was diagnosed, 
on average, 8.5 days after the onset of the varicella rash with 
an average minimal platelet count of 9500/mm3. Post-varicella 
ITP had an acute course in 80% of cases and a chronic course 
in the remaining 20%. The infection caused a relapse in 71% of 
the patients with chronic ITP but had no apparent affect on the 
platelet count of the children with acute ITP. Post-varicella ITP 
has similar clinical features and course to non-varicella associated 
ITP. The calculated risk of ITP as a complication after varicella 
infection was approximately 1:25,000 [2].
In the study of Rivest et al., frequency of thrombocytopenia 
associated with chickenpox in children was 22.5% [3]. Ware et al. 
described chronic thrombocytopenia in association with varicella 
in three girls [4]. Mantadakis et al. also reported chickenpox-
associated ITP [5]. Amir et al. describe bleeding complication in 
three patients with post-varicella ITP [2]. Tobin and Tobin and 
Ten Bensel, and Marcus et al. reported cases of varicella with 
thrombocytopenia causing fatal intracranial hemorrhage [6,7]. 
Various mechanisms have been implicated in its pathogenesis, 
including decreased bone marrow production of platelets, 
disseminated intravascular coagulation, viral-induced platelet 
aggregation followed by phagocytosis or lysis, direct viral 
invasion of platelet precursors, viral-derived neuraminidase 
causing enzymatic desialylation of platelets followed by removal 
of abnormal platelets by reticuloendothelial system, and immune-
mediated platelet destruction [5,8-10].
Platelet-specific IgM antibody against various platelet surface 
glycoproteins (GP), namely, GPIb, GPIIb, GPIIIa, and GPV were 
found in patients with varicella-associated thrombocytopenia 
by immunoblotting technique [8,11]. In our case, the child has 
thrombocytopenia when he was recovering from the illness. RBC 
and WBC counts and coagulation profile were within normal 
limits range. The child has active bleeding from both nostrils, 
causing a decline in Hb level and leading to anemia, a potential 
life-threatening situation, which needed nasal packing and platelet 
transfusion to control it.
Bone marrow examination is not indicated in acute ITP 
with typical features, which includes, Hb level of >10 g/dL 
(6-12 months of age) or >11 g/dL (older than 1 year), total WBC 
count of >5 × 109/L (6-60 months of age) or >4 × 109/L (>6 years), 
neutrophil count of >1.5 × 109/L (6 months-6 years) or >2 × 109/L 
(>6 years), and a platelet count of <50 × 109/L [12]. Children who 
did not meet the above criteria are categorized as atypical ITP, 
as in our case having Hb level of 8.1 g/dL, and may need bone 
marrow examination. Diagnosis of ITP is based on findings of 
clinical examination and peripheral blood smear in all cases, and 
bone marrow aspiration in some. Even with state-of-the-art tests 
including anti-platelet antibodies, thrombopoietin, glycocalicin, 
and platelet reticulocyte counts, immune thrombocytopenia cannot 
be distinguished from other thrombocytopenia’s and diagnosis 
is established by ruling out the other systemic processes [13]. 
Diagnosis of varicella is usually made clinically. However, when 
clinical diagnosis is a challenge, laboratory test is helpful, which 
includes varicella antibody titer in serum and detecting VZV in 
skin lesion with polymerase chain reaction.
Winiarski et al. quantities platelet-associated (PA) Igs and 
complement factors (C3, C4) and found that PA Igs were elevated 
in 98% patients of acute and chronic idiopathic thrombocytopenic 
purpura. PA IgG was elevated in 95%, PA IgA in 82%, and PA IgM 
in 74% of the patients. PAC3 and PAC4 were elevated in 86% 
and 57% of the patients, respectively. In acute ITP, PAC3 was 
strongly correlated with PA IgG than PAC4; while in chronic ITP, 
PAC4 correlated strongly with PA IgG than PAC3 [14]. In another 
study, percentage of elevated PAC3 values was found higher 
in thrombocytopenic patients than in non-thrombocytopenic 
patients. However, no statistically significant correlation was 
found between platelet counts and PAC3 levels [15]. In our case, 
we are not able to do PA Igs and complement levels.
Rapid improvement in thrombocytopenia with corticosteroid 
treatment along with bone marrow findings of normal myeloid and 
elytroid series with an increased number of megakaryocytes are 
suggestive of immune mediated mechanism of thrombocytopenia 
in our case. Both corticosteroids and intravenous Igs can be used to 
treat varicella-induced thrombocytopenia. Corticosteroids during 
the incubation period of varicella can lead to the development of 
visceral varicella, so they should be used in recovery phase past the 
incubation period [5]. Although fatal intracranial hemorrhage is 
reported with some cases of varicella-induced thrombocytopenic 
purpura, most of the reports describe quick recovery, showing 
excellent prognosis.
CONCLUSION
Thrombocytopenia is commonly reported with varicella having 
various immune and non-immune mechanisms with an overall 
Vol 4 | Issue 4 | Oct - Dec 2017 Indian J Child Health 643
Kumar Varicella-associated immune thrombocytopenic purpura
excellent prognosis, but it can also lead to life-threatening 
bleeding complications.
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